These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 28040716)

  • 1. NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017.
    Daly MB; Pilarski R; Berry M; Buys SS; Farmer M; Friedman S; Garber JE; Kauff ND; Khan S; Klein C; Kohlmann W; Kurian A; Litton JK; Madlensky L; Merajver SD; Offit K; Pal T; Reiser G; Shannon KM; Swisher E; Vinayak S; Voian NC; Weitzel JN; Wick MJ; Wiesner GL; Dwyer M; Darlow S
    J Natl Compr Canc Netw; 2017 Jan; 15(1):9-20. PubMed ID: 28040716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 1.2020.
    Daly MB; Pilarski R; Yurgelun MB; Berry MP; Buys SS; Dickson P; Domchek SM; Elkhanany A; Friedman S; Garber JE; Goggins M; Hutton ML; Khan S; Klein C; Kohlmann W; Kurian AW; Laronga C; Litton JK; Mak JS; Menendez CS; Merajver SD; Norquist BS; Offit K; Pal T; Pederson HJ; Reiser G; Shannon KM; Visvanathan K; Weitzel JN; Wick MJ; Wisinski KB; Dwyer MA; Darlow SD
    J Natl Compr Canc Netw; 2020 Apr; 18(4):380-391. PubMed ID: 32259785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of women at risk for hereditary breast and ovarian cancer in a sample of 1000 Slovenian women: a comparison of guidelines.
    Kotnik U; Peterlin B; Lovrecic L
    BMC Cancer; 2021 Jun; 21(1):665. PubMed ID: 34082720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2015.
    Daly MB; Pilarski R; Axilbund JE; Berry M; Buys SS; Crawford B; Farmer M; Friedman S; Garber JE; Khan S; Klein C; Kohlmann W; Kurian A; Litton JK; Madlensky L; Marcom PK; Merajver SD; Offit K; Pal T; Rana H; Reiser G; Robson ME; Shannon KM; Swisher E; Voian NC; Weitzel JN; Whelan A; Wick MJ; Wiesner GL; Dwyer M; Kumar R; Darlow S
    J Natl Compr Canc Netw; 2016 Feb; 14(2):153-62. PubMed ID: 26850485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and management of familial breast cancer in Austria.
    Singer CF; Tan YY; Rappaport C
    Horm Mol Biol Clin Investig; 2017 Nov; 32(2):. PubMed ID: 29190211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Colorectal, Version 3.2017.
    Gupta S; Provenzale D; Regenbogen SE; Hampel H; Slavin TP; Hall MJ; Llor X; Chung DC; Ahnen DJ; Bray T; Cooper G; Early DS; Ford JM; Giardiello FM; Grady W; Halverson AL; Hamilton SR; Klapman JB; Larson DW; Lazenby AJ; Lynch PM; Markowitz AJ; Mayer RJ; Ness RM; Samadder NJ; Shike M; Sugandha S; Weiss JM; Dwyer MA; Ogba N
    J Natl Compr Canc Netw; 2017 Dec; 15(12):1465-1475. PubMed ID: 29223984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NCCN Guidelines Insights: Hepatobiliary Cancers, Version 1.2017.
    Benson AB; D'Angelica MI; Abbott DE; Abrams TA; Alberts SR; Saenz DA; Are C; Brown DB; Chang DT; Covey AM; Hawkins W; Iyer R; Jacob R; Karachristos A; Kelley RK; Kim R; Palta M; Park JO; Sahai V; Schefter T; Schmidt C; Sicklick JK; Singh G; Sohal D; Stein S; Tian GG; Vauthey JN; Venook AP; Zhu AX; Hoffmann KG; Darlow S
    J Natl Compr Canc Netw; 2017 May; 15(5):563-573. PubMed ID: 28476736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guidelines Insights: Hepatobiliary Cancers, Version 2.2019.
    Benson AB; D'Angelica MI; Abbott DE; Abrams TA; Alberts SR; Anaya DA; Anders R; Are C; Brown D; Chang DT; Cloyd J; Covey AM; Hawkins W; Iyer R; Jacob R; Karachristos A; Kelley RK; Kim R; Palta M; Park JO; Sahai V; Schefter T; Sicklick JK; Singh G; Sohal D; Stein S; Tian GG; Vauthey JN; Venook AP; Hammond LJ; Darlow SD
    J Natl Compr Canc Netw; 2019 Apr; 17(4):302-310. PubMed ID: 30959462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hereditary breast cancer: an update on risk assessment and genetic testing in 2015.
    Stuckey AR; Onstad MA
    Am J Obstet Gynecol; 2015 Aug; 213(2):161-5. PubMed ID: 25747548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: Recommendation Statement.
    Am Fam Physician; 2020 Feb; 101(4):233-238. PubMed ID: 32053325
    [No Abstract]   [Full Text] [Related]  

  • 11. Eligibility Criteria and Genetic Testing Results from a High-Risk Cohort for Hereditary Breast and Ovarian Cancer Syndrome in Southeastern Ontario.
    Dos Santos Vidal R; Hawrysh A; Walia JS; Davey S; Feilotter H
    J Mol Diagn; 2016 May; 18(3):362-369. PubMed ID: 26941049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metastatic colon cancer, version 3.2013: featured updates to the NCCN Guidelines.
    Benson AB; Bekaii-Saab T; Chan E; Chen YJ; Choti MA; Cooper HS; Engstrom PF; Enzinger PC; Fakih MG; Fenton MJ; Fuchs CS; Grem JL; Hunt S; Kamel A; Leong LA; Lin E; May KS; Mulcahy MF; Murphy K; Rohren E; Ryan DP; Saltz L; Sharma S; Shibata D; Skibber JM; Small W; Sofocleous CT; Venook AP; Willett CG; Gregory KM; Freedman-Cass DA
    J Natl Compr Canc Netw; 2013 Feb; 11(2):141-52; quiz 152. PubMed ID: 23411381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multi-gene panel study in hereditary breast and ovarian cancer in Colombia.
    Cock-Rada AM; Ossa CA; Garcia HI; Gomez LR
    Fam Cancer; 2018 Jan; 17(1):23-30. PubMed ID: 28528518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prenatal genetic counseling practices regarding recommendations for cancer genetic counseling: A retrospective chart review from two academic institutions.
    Saba LF; Sullivan CM; Solomon T; Huguenard S; Nassef SA
    J Genet Couns; 2022 Oct; 31(5):1062-1070. PubMed ID: 35434961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time to incorporate germline multigene panel testing into breast and ovarian cancer patient care.
    Graffeo R; Livraghi L; Pagani O; Goldhirsch A; Partridge AH; Garber JE
    Breast Cancer Res Treat; 2016 Dec; 160(3):393-410. PubMed ID: 27734215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Localized colon cancer, version 3.2013: featured updates to the NCCN Guidelines.
    Benson AB; Bekaii-Saab T; Chan E; Chen YJ; Choti MA; Cooper HS; Engstrom PF; Enzinger PC; Fakih MG; Fenton MJ; Fuchs CS; Grem JL; Hunt S; Kamel A; Leong LA; Lin E; May KS; Mulcahy MF; Murphy K; Rohren E; Ryan DP; Saltz L; Sharma S; Shibata D; Skibber JM; Small W; Sofocleous CT; Venook AP; Willett CG; Gregory KM; Freedman-Cass DA;
    J Natl Compr Canc Netw; 2013 May; 11(5):519-28. PubMed ID: 23667203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rectal Cancer, Version 2.2015.
    Benson AB; Venook AP; Bekaii-Saab T; Chan E; Chen YJ; Cooper HS; Engstrom PF; Enzinger PC; Fenton MJ; Fuchs CS; Grem JL; Grothey A; Hochster HS; Hunt S; Kamel A; Kirilcuk N; Leong LA; Lin E; Messersmith WA; Mulcahy MF; Murphy JD; Nurkin S; Rohren E; Ryan DP; Saltz L; Sharma S; Shibata D; Skibber JM; Sofocleous CT; Stoffel EM; Stotsky-Himelfarb E; Willett CG; Gregory KM; Freedman-Cass D
    J Natl Compr Canc Netw; 2015 Jun; 13(6):719-28; quiz 728. PubMed ID: 26085388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Perils of Single-Site Genetic Testing for Hereditary Cancer Syndromes in the Era of Next-Generation Sequencing.
    Casasanta N; Stark E; McHenry A; Biagi T; Kaltman R
    Oncologist; 2018 Apr; 23(4):393-396. PubMed ID: 29445031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.
    Daly MB; Pal T; Berry MP; Buys SS; Dickson P; Domchek SM; Elkhanany A; Friedman S; Goggins M; Hutton ML; ; Karlan BY; Khan S; Klein C; Kohlmann W; ; Kurian AW; Laronga C; Litton JK; Mak JS; ; Menendez CS; Merajver SD; Norquist BS; Offit K; Pederson HJ; Reiser G; ; Senter-Jamieson L; ; Shannon KM; Shatsky R; Visvanathan K; Weitzel JN; Wick MJ; Wisinski KB; Yurgelun MB; Darlow SD; Dwyer MA
    J Natl Compr Canc Netw; 2021 Jan; 19(1):77-102. PubMed ID: 33406487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NCCN Guidelines® Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2024.
    Daly MB; Pal T; Maxwell KN; Churpek J; Kohlmann W; AlHilli Z; Arun B; Buys SS; Cheng H; Domchek SM; Friedman S; Giri V; Goggins M; Hagemann A; Hendrix A; Hutton ML; Karlan BY; Kassem N; Khan S; Khoury K; Kurian AW; Laronga C; Mak JS; Mansour J; McDonnell K; Menendez CS; Merajver SD; Norquist BS; Offit K; Rash D; Reiser G; Senter-Jamieson L; Shannon KM; Visvanathan K; Welborn J; Wick MJ; Wood M; Yurgelun MB; Dwyer MA; Darlow SD
    J Natl Compr Canc Netw; 2023 Oct; 21(10):1000-1010. PubMed ID: 37856201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.